Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study-Reference-Cited by-同舟云学术

Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study

Published:2022-08-16 Issue:1 Volume:7 Page:157-166
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Annals of Gastroent Surgery

Author:

Igarashi Takamichi¹,Yamada Suguru²^ORCID,Hoshino Yui¹,Murotani Kenta³,Baba Hayato¹,Takami Hideki²,Yoshioka Isaku¹,Shibuya Kazuto¹,Kodera Yasuhiro²^ORCID,Fujii Tsutomu¹^ORCID

Affiliation:

1. Department of Surgery and Science, Faculty of Medicine, Academic Assembly University of Toyama Toyama Japan

2. Department of Gastroenterological Surgery (Surgery II) Nagoya University Graduate School of Medicine Nagoya Japan

3. Biostatistics Center, Graduate School of Medicine Kurume University Kurume Japan

Publisher

Wiley

Subject

Gastroenterology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ags3.12613

Reference37 articles.

1. Cancer statistics, 2019